Cargando…
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies
Given widespread use of spike antibody in generating coronavirus disease vaccines, SARS-CoV-2 nucleocapsid antibodies are increasingly used to indicate previous infection in serologic surveys. However, longitudinal kinetics and seroreversion are poorly defined. We found substantial seroreversion of...
Autores principales: | Loesche, Michael, Karlson, Elizabeth W., Talabi, Opeyemi, Zhou, Guohai, Boutin, Natalie, Atchley, Rachel, Loevinsohn, Gideon, Chang, Jun Bai Park, Hasdianda, Mohammad A., Okenla, Adetoun, Sampson, Elizabeth, Schram, Haley, Magsipoc, Karen, Goodman, Kirsten, Donahue, Lauren, MacGowan, Maureen, Novack, Lewis A., Jarolim, Petr, Baden, Lindsey R., Nilles, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423917/ https://www.ncbi.nlm.nih.gov/pubmed/35868337 http://dx.doi.org/10.3201/eid2809.220729 |
Ejemplares similares
-
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort
por: Finch, Emilie, et al.
Publicado: (2022) -
Factors affecting seroreversion by 6 months among healthcare workers in Connecticut
por: Althoff, A., et al.
Publicado: (2022) -
Temporal trend in the time to seroreversion in uninfected infants born to HIV seropositive mothers
por: Gulia, Jyoti, et al.
Publicado: (2006) -
Surveillance and Seroepidemiology
por: Jiles, Ruth, et al.
Publicado: (2014) -
Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling
por: Brazeau, Nicholas F., et al.
Publicado: (2022)